Skip to content
CTD // Fund

Newton Biocapital

Venture capital firm focused on early-stage life sciences companies targeting chronic health conditions

← Fund directory

Newton Biocapital

Belgium

Newton Biocapital is an institutional investor (Healthcare Startups) founded in 2017 and headquartered in Brussels, Belgium. Venture capital firm focused on early-stage life sciences companies targeting chronic health conditions. It is a hands-on investor that leverages its expertise to help its portfolio companies focus on the right indication and clinical trial design.

Stage
research, preclinical, clinical, seed, Series A, research, preclinical, clinical, seed, Series A
Check size
$3.4M-$11.5M
HQ
Brussels, Belgium
Founded
2017
Website
https://newtonbiocapital.com
LinkedIn
https://linkedin.com/company/newton-biocapital-fund
Institutional Investorbiotechlife sciencestherapeutics for chronic diseases (oncologyautoimmunemetabolicneurologicalinfectious diseases)

What they look for

European (Belgium, France, Netherlands, Germany) and Japanese biotech startups and spin-offs; promising solutions in chronic health conditions; strong scientific teams from academic centers

Related startups

AdvanceCOR

Developer of drugs and diagnostics for cardiovascular diseases.

Life Sciences · Planegg, Germany

Biomemory

Biomemory provides bio-digital data storage solutions, developing a petrol-free DNA synthesis and copy process based on synthetic biology for long-term data…

Life Sciences · Paris, France

mbiomics

mbiomics is a provider of a genomic-based platform for microbiome-based therapeutics development, designing and developing complex Live Biotherapeutic…

Life Sciences · Munich, Germany

📊 Ballpark pre-money for pipeline deals — estimate equity value before you diligence a round.

⚠️ Common pitch mistakes we see →

Preparing to pitch Newton Biocapital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →